TY  - JOUR
AU  - Cavalcanti, Fernando
AU  - Gonzalez-Rey, Elena
AU  - Delgado, Mario
AU  - Falo, Clara P
AU  - Mestre, Leyre
AU  - Guaza, Carmen
AU  - O'Valle, Francisco
AU  - Lufino, Michele M P
AU  - Xaus, Jordi
AU  - Mascaró, Cristina
AU  - Lunardi, Serena
AU  - Sacilotto, Natalia
AU  - Dessanti, Paola
AU  - Rotllant, David
AU  - Navarro, Xavier
AU  - Herrando-Grabulosa, Mireia
AU  - Buesa, Carlos
AU  - Maes, Tamara
PY  - 2022
DO  - 10.3390/pharmaceutics14071420
SN  - 1999-4923
UR  - http://hdl.handle.net/10668/21554
T2  - Pharmaceutics
AB  - Lysine specific demethylase 1 (LSD1; also known as KDM1A), is an epigenetic modulator that modifies the histone methylation status. KDM1A forms a part of protein complexes that regulate the expression of genes involved in the onset and progression of...
LA  - en
PB  - MDPI AG
KW  - KDM1A
KW  - epigenetics
KW  - multiple sclerosis
KW  - neuroinflammation
KW  - vafidemstat
KW  - Glutamates
KW  - Histone Demethylases
KW  - Epigenesis, Genetic
KW  - Lysine
KW  - Sphingosine-1-Phosphate Receptors
KW  - Multiple Sclerosis
KW  - Neurodegenerative Diseases
TI  - Efficacy of Vafidemstat in Experimental Autoimmune Encephalomyelitis Highlights the KDM1A/RCOR1/HDAC Epigenetic Axis in Multiple Sclerosis.
TY  - research article
VL  - 14
ER  -